Filing Flows › Comparisons › DYAI vs IMA
Dyadic International vs ImageneBio: DYAI and IMA compared
Dyadic International is the larger company: $961K of revenue in its latest quarter (Q2 2026) against $800K for ImageneBio (Q1 2025).
Where the money goes: DYAI and IMA
Dyadic International (DYAI) · Q2 2026
Dyadic International, Q2 2026: revenue $961K (-0.6% year over year), operating margin -213.7%, net loss $2.1M, operating cash flow −$1.8M. The chart follows the revenue to costs, profit and cash.
ImageneBio (IMA) · Q1 2025
ImageneBio, Q1 2025: revenue $800K, net loss $8.6M, operating cash flow −$10.6M. The chart follows the revenue to costs, profit and cash.
| Dyadic International (DYAI) | ImageneBio (IMA) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q1 2025 |
| Revenue | $961K | $800K |
| Revenue growth, Y/Y | -0.6% | — |
| Operating margin | -213.7% | n/m |
| Net earnings | −$2.1M | −$8.6M |
| Net margin | -221.0% | — |
| Operating cash flow | −$1.8M | −$10.6M |
Where the revenue comes from
Dyadic International
- Grant: $837K (87%)
- Research and Development: $124K (13%)
Questions
Which is bigger, Dyadic International or ImageneBio?
Dyadic International is the larger company: $961K of revenue in its latest quarter (Q2 2026) against $800K for ImageneBio (Q1 2025).
More: Dyadic International earnings · how Dyadic International makes money · ImageneBio earnings · how ImageneBio makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-Q filed May 8, 2025). Fiscal quarters can end on different dates. Not investment advice.